viernes, 13 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 9, 2026

Earnings live: Cleveland-Cliffs stock slides after revenue miss, Monday.com stock tanks

View original at finance.yahoo.com
Earnings live: Cleveland-Cliffs stock slides after revenue miss, Monday.com stock tanks The fourth quarter earnings season is more than halfway over, and the S&P 500 is on track for solid earnings growth…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • e.l.f.'s value proposition, powerhouse innovation and disruptive marketing engine continue to fuel the brands and the company remains confident in its ability to grow market share and deliver best-in-class growth in beauty

    80% confidence
  • Peloton expects subscriptions to decrease by 8% year over year to a range of 2.65 million to 2.67 million in fiscal Q3 and revenue between $605 million and $625 million, a 1% decline year over year

    80% confidence
  • As 2026 started, the negative situations affecting Cleveland-Cliffs have all improved

    80% confidence
  • If the 13% EPS growth rate holds, it would represent the 10th consecutive quarter of annual earnings growth for the S&P 500 and the fifth consecutive quarter of double-digit growth

    80% confidence
  • 59% of S&P 500 companies have reported fourth quarter results as of Feb. 6, and Wall Street analysts estimate a 13% increase in earnings per share for the fourth quarter

    80% confidence
  • HODL (hold on for dear life)

    80% confidence
  • Philip Morris expects earnings per share of $7.87 to $8.02 in 2026

    80% confidence
  • Three themes emerging from Q4 earnings season: capital expenditures and artificial intelligence, particularly in Big Tech; how companies are thinking about tariffs; and the K-shaped consumer

    80% confidence
  • Strategy's capital structure is stronger and more resilient today than ever before

    80% confidence
  • Despite the continued impact of US tariffs, strong demand supported by product competitiveness has led to increased sales volumes, and Toyota achieved a high level of profit due to price revisions

    80% confidence
  • Monday.com expects first quarter revenue of $338 million to $340 million and operating income of $37 million to $39 million

    80% confidence
  • Cleveland-Cliffs expects to ship 16.5 million to 17 million tons of steel in 2026

    80% confidence
  • Cleveland-Cliffs performance in 2025 was negatively affected by persistently weak production levels from the automotive sector, an expiring five-year slab contract becoming value-destructive, and a newly adverse dynamic in the Canadian market

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com
Earnings live: Cleveland-Cliffs stock slides after revenue miss, Monday.com stock tanks — Source | Via News | es.VIA.NEWS